Drotrecogin alfa (activated) does not affect intracellular production of interleukin-6 and tumor necrosis factor-α in endotoxin-stimulated human monocytes

Anesthesia and Analgesia

Volumn 101, Issue 6, 2005, Pages 1805-1808

  Czeslick, Elke G ^a   Nestler, Frank ^a   Simm, Andreas ^a   Struppert, Anja ^a   Sablotzki, Armin ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; DROTRECOGIN; ENDOTOXIN; INTERLEUKIN 6; LEPIRUDIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD; BLOOD SAMPLING; CYTOKINE PRODUCTION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN EXPERIMENT; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 28344455436     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000184201.11804.4C     Document Type: Article

References (11)

1. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
2. Schmidt-Supprian M, Murphy C, White B, et al. Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. Eur Cytokine Netw 2000;11:407-13.
3. Yuksel M, Okajima K, Uchiba M, et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-αproduction by inhibiting activation of both nuclear factor-κ B and activator protein-1 in human monocytes. Thromb Haemost 2002;88:267-73.
4. Derhaschnig U, Reiter R, Knöbl P, et al. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 2003;102:2093-8.
5. Dhainaut JF, Yan SB, Margolis BD, et al. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis. Thromb Haemost 2003;90:642-53.
6. Czeslick EG, Simm A, Grond S, et al. Inhibition of intracellular tumor necrosis factor (TNF)-α and interleukin (IL)-6 production in human monocytes by iloprost. Eur J Clin Invest 2003;33:1013-7.
7. Röntgen P, Sablotzki A, Simm A, et al. Effect of catecholamines on intracellular cytokine synthesis in human monocytes. Eur Cytokine Netw 2004;15:14-23.
8. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med 2002;30:64-73.
9. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999;180:1584-9.
10. Macias WL, Dhainaut JF, Yan SB, et al. Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis. Clin Pharmacol Ther 2002;72:391-402.
11. White B, Schmidt M, Murphy C, et al. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κ B (NF-κ B) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000;110:130-4.